StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$2.05−0.12 (-5.53%)

Close on Nov 17, 2026Market cap $130.59MP/E –Yield –

MacroGenics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

MacroGenics's market cap was $147.66M on Nov 11, 2026, against $96.79M a year earlier. Over the last 5 years it ranged from $76.34M to $1.11B, with a median of $245.67M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$147.66M+45.0%
2025Dec 31, 2025$101.85M-50.1%
2024Dec 31, 2024$203.98M-65.8%
2023Dec 29, 2023$596.72M+44.7%
2022Dec 30, 2022$412.41M-58.1%
2021Dec 31, 2021$983.14M-23.4%
2020Dec 31, 2020$1.28B+141.3%
2019Dec 31, 2019$532.19M-0.8%
2018Dec 31, 2018$536.55M-23.3%
2017Dec 29, 2017$699.34M-1.7%
2016Dec 30, 2016$711.58M-32.9%
2015Dec 31, 2015$1.06B+8.9%
2014Dec 31, 2014$973.97M+1571.2%
2013Dec 31, 2013$58.28M–

More MacroGenics figures

See a number that looks wrong?